Abbott Laboratories (ABT) Total Assets by Year
Abbott Laboratories closed fiscal year 2025 with $86.7B in total assets, $34.6B in total liabilities and $52.1B in shareholder equity. Total assets rose 6.5% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Abbott Laboratories has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ABT Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $86.7B+6.5% | $81.4B+11.2% | $73.2B-1.6% | $74.4B-1.0% | $75.2B+3.6% | $72.5B+6.9% | $67.9B+1.1% | $67.2B-11.9% | $76.3B+44.8% | $52.7B+27.7% | $41.2B+0.1% | $41.2B-4.0% | $42.9B-36.1% | $67.2B+11.5% | $60.3B |
| Total Liabilities | $34.6B+2.5% | $33.8B-2.5% | $34.6B-8.3% | $37.8B-4.2% | $39.4B-0.9% | $39.8B+8.1% | $36.8B+0.4% | $36.6B-19.2% | $45.4B+41.2% | $32.1B+60.4% | $20.0B+1.8% | $19.7B+10.8% | $17.8B-56.1% | $40.5B+13.1% | $35.8B |
| Total Equity | $52.1B+9.4% | $47.7B+23.5% | $38.6B+5.2% | $36.7B+2.5% | $35.8B+9.2% | $32.8B+5.5% | $31.1B+1.8% | $30.5B-1.2% | $30.9B+50.4% | $20.5B-3.2% | $21.2B-1.5% | $21.5B-14.5% | $25.2B-5.8% | $26.7B+9.3% | $24.4B |
ABT Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $109.2B+30.0% | $110.4B+35.6% | $86.7B+6.5% | $84.2B+13.2% | $84.0B+15.0% | $81.4B+12.4% | $81.4B+11.2% | $74.4B+3.1% | $73.0B-0.5% | $72.5B-1.8% | $73.2B-1.6% | $72.1B-1.0% |
| Total Liabilities | $58.1B+73.8% | $58.4B+78.8% | $34.6B+2.5% | $33.2B-3.9% | $33.4B-0.8% | $32.6B-3.0% | $33.8B-2.5% | $34.6B-0.1% | $33.7B-6.9% | $33.7B-8.5% | $34.6B-8.3% | $34.6B-6.8% |
| Total Equity | $51.1B+1.1% | $52.1B+6.7% | $52.1B+9.4% | $51.0B+28.0% | $50.6B+28.6% | $48.8B+25.8% | $47.7B+23.5% | $39.8B+6.2% | $39.3B+5.8% | $38.8B+4.9% | $38.6B+5.2% | $37.5B+5.1% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Abbott Laboratories financials
Frequently Asked Questions
What was Abbott Laboratories's total assets in fiscal year 2025?
Abbott Laboratories closed fiscal year 2025 with $86.7B in total assets, $34.6B in total liabilities and $52.1B in shareholder equity.
How fast is Abbott Laboratories's total assets growing?
Abbott Laboratories (ABT) total assets rose by 6.5% year over year, from $81.4B to $86.7B in fiscal year 2025.
How has Abbott Laboratories's total assets changed over the years?
Across the 15 fiscal years this page covers, Abbott Laboratories (ABT) total assets went from $60.3B in fiscal year 2011 to $86.7B in fiscal year 2025.
What was Abbott Laboratories's total assets in the most recent quarter?
Abbott Laboratories (ABT) reported $109.2B in total assets in Q2 2026. This represents an increase of 30.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Abbott Laboratories (ABT) reported on that line in every period on record.